SCHEMBL10345941

SCHEMBL10345941

COc1cc2c(cc1S(=O)(=O)Cl)CCN(C(C)=O)CC2c1ccc(S(=O)(=O)Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ ADAM17 P78536 1/20 0.41
▸ CA1 P00915 9/20 0.41
▸ CA2 P00918 9/20 0.41
▸ CA9 Q16790 9/20 0.41
▸ CA14 Q9ULX7 9/20 0.41
▸ CA7 P43166 6/20 0.41
▸ CA12 O43570 4/20 0.41
▸ TRPV1 Q8NER1 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10744445 0.94 CYP3A4 (0.41) CYP3A4CYP2D6ADAM17CA1CA2
SCHEMBL10345899 0.91 CYP2D6 (0.53) CYP3A4CYP2D6ADAM17CA1CA2
SCHEMBL10748134 0.87 CYP3A4 (0.43) CYP3A4CYP2D6ADAM17CA1CA2
SCHEMBL10345840 0.87 CYP2D6 (0.53) CYP3A4CYP2D6ADAM17CA1CA2
SCHEMBL10746813 0.82 CYP3A4 (0.54) CYP3A4CYP2D6ADAM17CA1CA2
SCHEMBL10345859 0.81 CYP2D6 (0.53) CYP3A4CYP2D6ADAM17CA1CA2
SCHEMBL10749624 0.81 CYP3A4 (0.38) CYP3A4CYP2D6ADAM17CA1CA2
SCHEMBL10350477 0.77 CA7 (0.44) CA1CA2CA9CA14CA7
SCHEMBL10345670 0.73 MMP1 (0.46) CYP3A4CYP2D6
SCHEMBL10743718 0.71 CYP3A4 (0.53) CYP3A4CYP2D6ADAM17CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230755-B1 1-PHENYL-3-BENZAZEPINES SMITHKLINE BEECHAM CORPORATION (US) 1990-05-16 — — EP disclosed
US-4707483-A 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders SMITHKLINE BECKMAN CORPORATION (US) 1987-11-17 — — US disclosed
EP-0244088-A2 1-Phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders SMITHKLINE BEECHAM CORPORATION (US) 1987-11-04 — — EP disclosed
EP-0230755-A1 1-Phenyl-3-benzazepines SMITHKLINE BEECHAM CORPORATION (US) 1987-08-05 — — EP disclosed
Send feedback